10-K Decoder · All companies

Maravai LifeSciences Holdings, Inc.

MRVI · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$186M$259M−28.3%
Operating income−$215M−$236M+8.6%
Net income−$131M−$145M+9.7%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$45.9M$41.6M+10.3%
Operating income−$20.6M−$41.0M+49.8%
Net income−$13.8M−$25.6M+46.1%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Maravai LifeSciences's revenue in FY2025?
$186M in FY2025 (Fiscal year ended Dec 31, 2025), −28.3% vs $259M a year earlier, per its 10-K filed Feb 2026.
Was Maravai LifeSciences profitable in FY2025?
No: net income was −$131M and operating income −$215M in FY2025.
What was Maravai LifeSciences's revenue in Q3 2026?
$45.9M (+10.3% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.